Sandy Demay is a seasoned professional in mRNA drug substance development, currently serving as the mRNA CMC Drug Substance Development Leader at Sanofi. With extensive experience in upstream processes, GMP manufacturing, and bioprocess optimization, Sandy has held various roles at Sanofi, including Upstream Microbial Bioprocess Expert and Project Leader in Bacteriology. Earlier in their career, Sandy worked as a Bacteriologist Engineer at Vétoquinol and participated in bacterial fermentation at Merial. In addition to their industry work, Sandy has been a guest lecturer at CPE Lyon, sharing expertise in fermentation processes. They hold a Diplôme d'ingénieur in Biochemistry from the Institut national des Sciences appliquées de Toulouse and have a background in biomedical sciences from The University of Glasgow.
This person is not in the org chart
This person is not in any teams
This person is not in any offices